Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 3

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Jan 21, 2005; 11(3): 400-402
Published online Jan 21, 2005. doi: 10.3748/wjg.v11.i3.400

$[Label] $[Caption]

$[Table]

$[Footnotes]

Citation: Lapinski TW, Flisiak R, Jaroszewicz J, Michalewicz M, Kowalczuk O. Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation. World J Gastroenterol 2005; 11(3): 400-402
URL: https://www.wjgnet.com/1007-9327/full/v11/i3/400.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i3.400

Lapinski TW, Flisiak R, Jaroszewicz J, Michalewicz M, Kowalczuk O. Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation. World J Gastroenterol 2005; 11(3): 400-402 [PMID: 15637753 DOI: 10.3748/wjg.v11.i3.400]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.